Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Average (2022 - 2025)

Envoy Medical's Equity Average history spans 4 years, with the latest figure at -$18.8 million for Q3 2025.

  • For Q3 2025, Equity Average fell 21.25% year-over-year to -$18.8 million; the TTM value through Sep 2025 reached -$18.8 million, down 21.25%, while the annual FY2024 figure was -$10.3 million, 45.7% up from the prior year.
  • Equity Average for Q3 2025 was -$18.8 million at Envoy Medical, up from -$27.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $1.5 million in Q4 2023 and bottomed at -$46.3 million in Q2 2023.
  • The 4-year median for Equity Average is -$20.8 million (2023), against an average of -$21.8 million.
  • The largest annual shift saw Equity Average soared 104.88% in 2023 before it crashed 1342.03% in 2024.
  • A 4-year view of Equity Average shows it stood at -$30.9 million in 2022, then skyrocketed by 104.88% to $1.5 million in 2023, then plummeted by 1342.03% to -$18.7 million in 2024, then fell by 0.36% to -$18.8 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Equity Average are -$18.8 million (Q3 2025), -$27.0 million (Q2 2025), and -$21.5 million (Q1 2025).